NCT01872013View on ClinicalTrials.gov

Multiple Oral Administration of ASP7991 to Non-elderly Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
HealthyPharmacokinetics of ASP7991
Interventions
DRUG

ASP7991

oral

DRUG

Placebo

oral

Trial Locations (1)

Unknown

Tokyo

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY